Morgan Stanley announced on Thursday that it has downgraded Affirm Holdings to Equal-weight from Overweight and has taken the stock off its Top Pick list. The firm described the move as driven by valuation, while maintaining that its structural view of Affirm remains unchanged.
Analyst James Faucette told investors the decision was "a valuation call, not a structural one," and emphasized that Morgan Stanley's confidence in Affirm's long-term position has not eroded. In his note, Faucette described Affirm as "one of the highest quality fintech assets in our coverage," pointing to what the bank sees as superior management, differentiated product capabilities, and direct exposure to buy now, pay later category share gains.
The bank said that the three principal uncertainties that had prompted its earlier upgrade - GMV durability, funding execution and credit performance - "have largely been resolved." Morgan Stanley highlighted Affirm's demonstrated "programmatic and best-in-class execution across ABS and forward flow channels." Those developments and related estimate revisions have supported a significant run-up in the stock.
As part of those revisions, Morgan Stanley's fiscal year 2028 GAAP EPS estimate for Affirm rose to $3.37 from $2.95 in early February, a figure the bank noted is well above the street consensus of $2.50. Despite that upward revision, Morgan Stanley said substantially higher revisions - toward "$4.50 to $5 of FY28 GAAP EPS" - would be necessary to justify continued sponsorship at current market levels.
The firm left its $79 price target and its underlying estimates unchanged while describing its stance as "stepping to the sidelines awaiting a more attractive entry point." The move reflects a shift from active endorsement to a more neutral positioning until valuation becomes more compelling relative to the bank's expectations for future earnings.
Sectors impacted: fintech, payments, consumer credit and financial services.